Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Cronos Australia Ltd. ( (AU:VIT) ) just unveiled an announcement.
Vitura Health Limited will host an investor webinar at 9:00am AEDT on 26 February 2026 to present its half-year financial results for the period ended 31 December 2025. The online session will include a results presentation followed by a Q&A segment, giving investors direct access to management and further insight into the company’s operational performance and strategic direction.
The update comes as Vitura continues to expand its integrated digital health platform, spanning medicinal cannabis distribution, nationwide telehealth services and a growing focus on psychedelics. The half-year results briefing is likely to provide stakeholders with clarity on how these diversified assets are contributing to revenue, market positioning and the scalability of its end-to-end healthcare ecosystem.
The most recent analyst rating on (AU:VIT) stock is a Hold with a A$0.06 price target. To see the full list of analyst forecasts on Cronos Australia Ltd. stock, see the AU:VIT Stock Forecast page.
More about Cronos Australia Ltd.
Vitura Health Limited is an ASX-listed diversified digital health business focused on medicinal cannabis distribution, telehealth and emerging psychedelic therapies. Through its Canview platform, the company operates an end-to-end online ecosystem linking prescribers, patients, pharmacies and suppliers, distributing around 600 therapeutic products from about 70 brands to roughly 4,700 pharmacies across Australia. It also owns telehealth provider Doctors on Demand, cannabis-focused Candor Medical, and stakes in psychedelic supplier Cortexa and Releaf-branded medicinal cannabis clinics, supported by licensed distribution centres in Melbourne and the Gold Coast.
Average Trading Volume: 244,236
Technical Sentiment Signal: Sell
Current Market Cap: A$31.81M
See more data about VIT stock on TipRanks’ Stock Analysis page.